Targretin is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Valeant Pharmaceuticals North America Llc. The primary component is Bexarotene.
| Product ID | 0187-5525_09f19705-7d90-4270-ad11-d4d01c756611 |
| NDC | 0187-5525 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Targretin |
| Generic Name | Bexarotene |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2000-06-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021056 |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | BEXAROTENE |
| Active Ingredient Strength | 1 g/100g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2000-06-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021056 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2000-06-28 |
| Ingredient | Strength |
|---|---|
| BEXAROTENE | 1 g/100g |
| SPL SET ID: | d35b4697-3f3b-4aa1-b5d9-153993e83811 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0187-5525 | Targretin | bexarotene |
| 0187-5526 | Targretin | bexarotene |
| 0054-0399 | Bexarotene | bexarotene |
| 0378-6955 | Bexarotene | Bexarotene |
| 0591-2832 | bexarotene | bexarotene |
| 0832-0285 | Bexarotene | Bexarotene |
| 42292-007 | Bexarotene | Bexarotene |
| 43975-315 | Bexarotene | Bexarotene |
| 68682-002 | bexarotene | bexarotene |
| 68682-003 | bexarotene | bexarotene |
| 69238-1250 | Bexarotene | Bexarotene |
| 69238-2088 | Bexarotene | Bexarotene |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TARGRETIN 75840727 2464596 Live/Registered |
VALEANT PHARMACEUTICALS INTERNATIONAL, I 1999-11-04 |
![]() TARGRETIN 74700262 2149626 Live/Registered |
VALEANT PHARMACEUTICALS INTERNATIONAL, I 1995-07-12 |